Neurology

Several risk factors for multiple sclerosis, such as disease progression and fatigue, increase the risk of unemployment.

Women who had longer reproductive periods during their lifetimes were found to have a greater risk of dementia in older age compared with those who had shorter reproductive periods.

Dimethyl fumarate is indicated to treat relapsing forms of multiple sclerosis in adult patients.

Integrating specialty pharmacy staff into oncology, neurology, rheumatology, and other specialty clinics within their health systems is a growing trend with a range of beneficial outcomes.

Individuals with asymptomatic Alzheimer disease are more likely to fall than those who are not on track to develop dementia.

Pregnancy may help put off the onset of multiple sclerosis symptoms by more than 3 years.

There were a number of FDA approvals in 2019 that were either the first new therapies or first in class approved for certain conditions, and the specialty pipeline is continuing to grow at a rapid pace.

In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.

An investigational drug for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been shown to slow the progression of the disease.

There is a new study that discovered certain drugs cause problems in healthy people who do not have risk factors or family members with dementia.

Research suggests that those with progressive multiple sclerosis may have adjusted more effectively to lockdown conditions.

Although there is no underlying mechanism specifically associating cognitive and visual impairment, the investigators noted that the relationship between cognitive and visual function is likely bidirectional and multifactorial.

Post-menopausal women are at a heightened risk of Alzheimer disease.

Individuals with a higher risk of cardiovascular disease (CVD) demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease, according to the results of a recent study.

Flavonoids are natural substances found in plants, including fruits and vegetables, and are associated with various health benefits, such as reduced inflammation.

Contrary to previous studies, the rate of cognitive impairment has increased over the past 20 years.

The FDA has approved Nurtec ODT (rimegepant) from Biohaven Pharmaceuticals to treat acute migraines with or without aura in adults.

A new medication for certain rare blood cancers has now become available through a limited distribution with AllianceRx Walgreens Prime.

Although dementia-related deaths appear to be underreported overall, a study showed especially striking discrepancies for Black, male, and less educated older adults.

When telehealth is part of a larger personalized care plan tied specifically to a particular specialty drug, pharmacists can be better positioned to empower their patients.

New research suggests it is possible to treat cognitive decline with personalized, precision medicine.

Fingolimod (Gilenya), which is approved by the FDA to treat multiple sclerosis flare-ups, may also block HIV and reduce the latent reservoir.

Pharmaceutical treatments have been at a standstill, but promising drugs are on the horizon.

Ozanimod (Zeposia) became the third oral S1P modulator approved by the FDA for the treatment of multiple sclerosis,

A new blood test for Alzheimer disease could provide a more sensitive, accurate indicator of plaques and tangles corresponding to the disease in living people.